Warren Hosseinion
CIK 1438327 · View on SEC EDGAR ↗
First SEC filing: Aug. 6, 2013 · Latest: Nov. 3, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 14, 2018 | ASTH | S | 20,000 | $16.35 | $327,000 | 837,338 Direct | -2.33% | Disposed | 139.5% (price as of 2026-08-21) |
| June 13, 2018 | ASTH | S | 15,000 | $15.77 | $236,550 | 857,338 Direct | -1.72% | Disposed | 148.3% (price as of 2026-08-21) |
| June 12, 2018 | ASTH | S | 13,000 | $15.44 | $200,720 | 872,338 Direct | -1.47% | Disposed | 153.6% (price as of 2026-08-21) |
| June 11, 2018 | ASTH | S | 12,000 | $15.44 | $185,280 | 885,338 Direct | -1.34% | Disposed | 153.6% (price as of 2026-08-21) |
| June 8, 2018 | ASTH | S | 8,000 | $14.73 | $117,840 | 897,338 Direct | -0.88% | Disposed | 165.8% (price as of 2026-08-21) |
| June 7, 2018 | ASTH | S | 14,535 | $14.20 | $206,397 | 905,338 Direct | -1.58% | Disposed | 175.7% (price as of 2026-08-21) |
| June 6, 2018 | ASTH | S | 13,876 | $14.70 | $203,977 | 919,873 Direct | -1.49% | Disposed | 166.4% (price as of 2026-08-21) |
| June 5, 2018 | ASTH | S | 13,876 | $14.85 | $206,059 | 933,749 Direct | -1.46% | Disposed | 163.7% (price as of 2026-08-21) |
| June 4, 2018 | ASTH | S | 13,876 | $14.78 | $205,087 | 947,625 Direct | -1.44% | Disposed | 164.9% (price as of 2026-08-21) |
| June 1, 2018 | ASTH | S | 11,876 | $14.37 | $170,658 | 961,501 Direct | -1.22% | Disposed | 172.5% (price as of 2026-08-21) |
| May 31, 2018 | ASTH | S | 9,476 | $13.63 | $129,158 | 973,377 Direct | -0.96% | Disposed | 187.3% (price as of 2026-08-21) |
| May 30, 2018 | ASTH | S | 5,876 | $13.28 | $78,033 | 982,853 Direct | -0.59% | Disposed | 194.8% (price as of 2026-08-21) |
| May 29, 2018 | ASTH | S | 5,876 | $13.52 | $79,444 | 988,729 Direct | -0.59% | Disposed | 189.6% (price as of 2026-08-21) |
| May 25, 2018 | ASTH | S | 5,876 | $13.70 | $80,501 | 994,605 Direct | -0.59% | Disposed | 185.8% (price as of 2026-08-21) |
| May 24, 2018 | ASTH | S | 5,876 | $14.19 | $83,380 | 1,000,481 Direct | -0.58% | Disposed | 175.9% (price as of 2026-08-21) |
| May 23, 2018 | ASTH | S | 5,876 | $14.69 | $86,318 | 1,006,357 Direct | -0.58% | Disposed | 166.5% (price as of 2026-08-21) |
| May 22, 2018 | ASTH | S | 5,876 | $15.39 | $90,432 | 1,012,233 Direct | -0.58% | Disposed | 154.4% (price as of 2026-08-21) |
| May 21, 2018 | ASTH | S | 5,876 | $15.66 | $92,018 | 1,018,109 Direct | -0.57% | Disposed | 150.0% (price as of 2026-08-21) |
| May 18, 2018 | ASTH | S | 5,876 | $15.90 | $93,428 | 1,023,985 Direct | -0.57% | Disposed | 146.3% (price as of 2026-08-21) |
| Sept. 15, 2012 | ASTH | P | 1,000,000 | — | — | 10,123,387 Direct | +10.96% | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 15, 2018 | ASTH | Stock Option | Common Stock (22,476) | $6.37 | Feb. 14, 2021 | 22,476 | Disposed |
| Jan. 15, 2018 | ASTH | Stock Option | Common Stock (22,476) | $6.37 | Feb. 14, 2021 | 22,476 | Disposed |
| July 10, 2014 | ASTH | Options | Common Stock (200,000) | $1.00 | July 9, 2024 | 200,000 | Acquired |
| Dec. 9, 2010 | ASTH | Options | Common stock (300,000) | $0.15 | Dec. 7, 2020 | 300,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 9, 2026 | VRXAW | Ordinary Shares | 700,000 | Direct |
| Nov. 3, 2022 | CDIOW | Common Stock | 116,053 | Direct |
| Nov. 3, 2022 | CDIOW | Stock Options (right to buy)→ Common Stock (342,726) | 342,726 | Direct |
| Nov. 8, 2019 | NUTX | Common Stock | 151,801 | Direct |
| Nov. 8, 2019 | NUTX | Common Stock | 53,974 | Indirect |
| Nov. 8, 2019 | NUTX | Warrants→ Common Stock (21,590) | 21,590 | Indirect |
| June 24, 2008 | ASTH | Common Stock | 9,123,387 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ASTH
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $523,814 | $30,000 | — | — | — | — | $64,964 | $618,778 |
| 2016 | $383,378 | $30,000 | — | $347,000 | — | — | $108,646 | $869,024 |
| 2014 | $467,500 | — | — | — | — | — | $126,451 | $593,951 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $755,100 | $377,500 | — | — | — | — | — | $1,243,432 |
| 2021 | $342,805 | $150,000 | — | $964,602 | $0 | $0 | $375,263 | $1,307,407 |
| 2020 | $0 | $0 | — | $338,638 | $0 | $0 | $0 | $338,638 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $300,000 | $0 | — | $0 | — | — | $0 | $300,000 |
| 2024 | $300,000 | $0 | — | $75,349 | — | — | $0 | $375,349 |
| 2023 | $300,000 | $0 | — | $155,291 | — | — | $0 | $455,291 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.